| Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae? K Nurgali, RT Jagoe, R Abalo Frontiers in pharmacology 9, 362658, 2018 | 881 | 2018 |
| Chemotherapy-induced constipation and diarrhea: pathophysiology, current and emerging treatments RM McQuade, V Stojanovska, R Abalo, JC Bornstein, K Nurgali Frontiers in pharmacology 7, 223117, 2016 | 251 | 2016 |
| Antiproliferative and palliative activity of flavonoids in colorectal cancer J Fernandez, B Silván, R Entrialgo-Cadierno, CJ Villar, R Capasso, ... Biomedicine & Pharmacotherapy 143, 112241, 2021 | 190 | 2021 |
| Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease JA Uranga, V López-Miranda, F Lombó, R Abalo Pharmacological Reports 68 (4), 816-826, 2016 | 151 | 2016 |
| Cannabidiol and other non-psychoactive cannabinoids for prevention and treatment of gastrointestinal disorders: useful nutraceuticals? V Martínez, A Iriondo De-Hond, F Borrelli, R Capasso, MD Del Castillo, ... International Journal of Molecular Sciences 21 (9), 3067, 2020 | 120 | 2020 |
| Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica PA Cabezos, G Vera, M Castillo, R Fernández-Pujol, MI Martín, R Abalo Autonomic Neuroscience 141 (1-2), 54-65, 2008 | 94 | 2008 |
| Enteric neuropathy evoked by repeated cisplatin in the rat G Vera, M Castillo, PA Cabezos, A Chiarlone, MI Martín, A Gori, ... Neurogastroenterology & Motility 23 (4), 370-e163, 2011 | 83 | 2011 |
| Mechanisms of chemotherapy-induced neurotoxicity H Was, A Borkowska, A Bagues, L Tu, JYH Liu, Z Lu, JA Rudd, K Nurgali, ... Frontiers in pharmacology 13, 750507, 2022 | 81 | 2022 |
| WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat G Vera, A Chiarlone, PA Cabezos, D Pascual, MI Martín, R Abalo Life sciences 81 (6), 468-479, 2007 | 79 | 2007 |
| Effects of coffee and its components on the gastrointestinal tract and the brain–gut axis A Iriondo-DeHond, JA Uranga, MD Del Castillo, R Abalo Nutrients 13 (1), 88, 2020 | 75 | 2020 |
| Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy G Vera, PA Cabezos, MI Martín, R Abalo Pharmacology Biochemistry and Behavior 105, 205-212, 2013 | 74 | 2013 |
| Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5‐fluorouracil RM McQuade, V Stojanovska, E Donald, R Abalo, JC Bornstein, K Nurgali Neurogastroenterology & Motility 28 (12), 1861-1875, 2016 | 73 | 2016 |
| Cisplatin‐induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica PA Cabezos, G Vera, MI Martín‐Fontelles, R Fernández‐Pujol, R Abalo Neurogastroenterology & Motility 22 (7), 797-e225, 2010 | 72 | 2010 |
| The gastrointestinal pharmacology of cannabinoids: focus on motility R Abalo, G Vera, AE López-Pérez, M Martínez-Villaluenga, ... Pharmacology 90 (1-2), 1-10, 2012 | 70 | 2012 |
| Altered feeding behaviour induced by long-term cisplatin in rats G Vera, A Chiarlone, MI Martín, R Abalo Autonomic Neuroscience 126, 81-92, 2006 | 64 | 2006 |
| Cannabinoid/agonist WIN 55,212‐2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS C González, E Herradón, R Abalo, G Vera, BG Pérez‐Nievas, JC Leza, ... Diabetes/metabolism research and reviews 27 (4), 331-340, 2011 | 57 | 2011 |
| Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes G Vera, V López-Miranda, E Herradón, MI Martín, R Abalo Pharmacology Biochemistry and Behavior 102 (2), 335-343, 2012 | 51 | 2012 |
| Mast cell regulation and irritable bowel syndrome: effects of food components with potential nutraceutical use JA Uranga, V Martínez, R Abalo Molecules 25 (18), 4314, 2020 | 50 | 2020 |
| Gene expression of VIP receptor in rat lymphocytes RP Gomariz, E Garrido, J Leceta, C Martinez, R Abalo, M Delgado Biochemical and biophysical research communications 203 (3), 1599-1604, 1994 | 50 | 1994 |
| Cannabinoid pharmacology and therapy in gut disorders JA Uranga, G Vera, R Abalo Biochemical Pharmacology 157, 134-147, 2018 | 49 | 2018 |
Kulmira NurgaliProfessor, Victoria University, Melbourne, AustraliaVerified email at vu.edu.au
